Overview of the C31 system in A. gambiae The ΦC31 system uses the properties of the site-specific integrase from the bacteriophage ΦC31, which mediates recombination between an attachment site (attB) that is normally present in the genome of Streptomyces lividans and an attachment site (attP) that is present in the circular genome of the bacteriophage ΦC31. Recombination between the two att sites integrates the phage genome and forms two hybrid sites, attL and attR, which are not targets for the ΦC31 integrase; thus, the integration event is irreversible 32 .
To establish this system de novo in any organism, the first step is to integrate an attP site into the genome. In A. gambiae, this was initially performed using attP-tagged piggyBac transposons, which harbor a fluorescent marker gene under the control of the synthetic eye/nervous system-specific 3xP3 promoter, whose expression is easily visualized in mosquito larvae 33 (Fig. 1a) . The resulting transgenic lines are called 'docking strains'. The docking strains need to be characterized for homozygous fitness, to ensure line robustness, as well as the presence of single chromosomally integrated attP sites, to enable the production of phase two mosquitoes, described below, with integrase-mediated insertions at these unique, identical sites.
The second step is to co-inject embryos from the docking strain with a transgene carried on a plasmid containing an attB site and a source of the ΦC31 integrase to promote site-specific recombination in the germ cells of the injected embryos (Fig. 1b) . In most studies, in vitro-produced mRNA is used as a source of integrase 33, 34 , but plasmid templates have recently also proved to be suitable (A.L., unpublished data; S. Fuchs, T. Nolan and A. Crisanti, unpublished data) in mosquitoes. From this second step, also named phase two, establishment of homozygous lines is straightforward, as virtually all transgenics will have an identical transgene at the same location and therefore mass mating can be performed. This is important for A. gambiae, which is a mosquito species that mates in swarms. Increases in the transformation efficiency may also be derived from only using generation 0 (G 0 ) larvae that transiently express the marker gene to establish subsequent crosses, as our experience indicates that these are more likely to generate transgenic offspring (E.P. and N.P., unpublished data).
Advantages of the C31-based transgenesis system in A. gambiae
The ΦC31-based transgenesis system offers several advantages over other systems, which should be considered when adopting this technology. These advantages include (i) integration of transgenes at specific, characterized genomic locations; (ii) insertion of large constructs (larger than 42 kb, the size of the phage ΦC31 genome); (iii) irreversible integration of the transgene; (iv) the predominance of single gene insertions; and (vi) potential increases in transformation efficiency (see details in Fish et al. 35 ). Furthermore, it provides a simplified mating procedure to identify transformants, which should all be identical. This is a considerable benefit for A. gambiae that is not easily amenable to single-pair mating. Overall, the ability to mitigate position effects on transgene expression is likely to be of principal importance for most applications, allowing for more efficient comparison between transgenic lines during phenotypic characterization 31 .
In D. melanogaster, the efficiency of ΦC31-mediated transgenesis is reported to be approximately fivefold higher than that mediated by P element transposase 36 . However, in mosquitoes, extensive comparisons have not been described 31, 33, 37 . The overall benefit of the development of the ΦC31 system for producing transgenic A. gambiae has led to recent developments of novel tools in this mosquito, including a synthetic homing endonucleasebased gene drive system 34 and the transcription activator-like effector nuclease (TALEN) system for targeted mutagenesis 38 .
Further advances could be obtained by generating a minimal set of docking strains that bear an attP site on each of the three chromosomes of A. gambiae. To optimize fitness and efficiency of site-directed modification, these would need to be selected from a large batch of piggyBac-derived attP-carrying transgenics. These tools would aid the development of efficient conditional expression systems, including Gal4/UAS in A. gambiae. In addition to gain-of-function studies, such a system would also permit functional analysis of alleles by a combination of stable RNAi and in vivo complementation to alleviate the otherwise laborious process of allele-specific transient RNAi 18 .
One of the limitations of Anopheles transgenesis in general is the lack of a method for convenient line preservation, such as cold or dry storage. This means that lines may have to be reared continuously. Although efforts need to be focused on producing a b
Step The second phase is injecting into attP-containing embryos a plasmid containing an attB site, a fluorescence marker gene that is different from the one in the docking strain and the transgene along with a source for ΦC31 integrase to mediate site-specific recombination at the attP site. After recombination, attL and attR sites, insensitive to the integrase, are formed. As outlined in the main text, the source of integrase can be in vitro-transcribed mRNA 33 or a helper plasmid (A.L., unpublished data). In recently developed self-docking strains 41 , the integrase is produced in the attP-containing embryo germ line, and only the attB plasmid is injected into the embryos.
a suitable line preservation system, the relative efficiency of ΦC31 transformation combined with the ability to create lines with insertions in identical sites means that it is feasible to regenerate the lines de novo as required, rather than maintaining them for years.
Experimental design
Mosquito embryos. Regardless of the strategy chosen for producing transgenic A. gambiae mosquitoes, embryos will be exposed to stress from receiving exogenous nucleic acid material at the time of injection. Therefore, the quality of the embryos is paramount. Besides specific care of the adult females from which embryos are collected, it is highly important to rear the larval juvenile stages of these mothers in optimal, healthy conditions. Particular care should be given to larval density and larval food access. Although it is not based on extensive testing, our experience leads us to highly recommend use of embryos produced from the first egg batch of young females.
Designing attB-containing plasmids. The standard docking strains that are currently available harbor the ECFP marker gene. Therefore, a second fluorescent marker gene, usually YFP or DsRed, is necessary for efficient differentiation and selection of transgenics harboring the transgene of interest. To be able to screen transgenics at all postembryonic stages, the most convenient regulatory region to drive the selectable marker gene is currently the 3xP3 promoter, which yields expression in the eye and nervous system in mosquito larvae (Fig. 2a) . As the number of easily differentiated fluorescent proteins is not extensive, the choice of markers needs to be carefully evaluated with the help of published guides and on the basis of the availability of suitable filter sets 39 . Several plasmids with an attB site associated with different fluorescent proteins under the control of the 3xP3 promoter have been already constructed for ΦC31 integrasemediated transformation of Aedes and Anopheles mosquitoes and are available from the respective laboratories 33,37,40,41 .
Additional constructs developed for Drosophila might also be considered 42 .
C31 integrase source. To establish the procedure for the ΦC31 integrase-based transformation system in Anopheles, as well as in Aedes mosquitoes 31, 37, 40 , in Bombyx mori 43 and in Drosophila 35, 36 , in vitro-transcribed mRNA was used as a source for ΦC31 integrase. The use of mRNA is particularly suitable for non-model organisms, as it does not rely on specific promoters to drive the expression of integrase in the germ line. However, as integrase mRNA is prone to degradation if precautions are not adhered to, there can be variability in transformation efficiency 35 . An alternative way to provide the ΦC31 integrase is to co-inject helper plasmid, which is inherently more stable than mRNA. The recent successful use of the pKC40 helper plasmid 44 in six independent experiments (A.L., unpublished data) showed that this is efficient, although direct comparison of relative efficiency against mRNA has not been performed. The pKC40 plasmid carries the gene encoding ΦC31 integrase, with an additional carboxyl nuclear localization sequence, driven by the Drosophila hsp70 promoter. The recent development of additional helper plasmids driving integrase expression under germlinespecific promoters such as nanos or vasa (S. Fuchs, T. Nolan and A. Crisanti, unpublished data) may also contribute to the overall increased convenience of the system. Further sophistication of the A. gambiae system has been achieved 41 through the development of self-docking strains that carry a genomic source of integrase similar to that described in Drosophila 42 . In these strains, the ΦC31 integrase is expressed specifically in the germ line; therefore, only the attB plasmid containing the transgene needs to be injected into the embryos, resulting in an increased survival rate up to 60%. This system has proved to be efficient 41 self-docking strains were designed to be excised using Cre-loxP after site-specific integration (J.M.M. and P.E., unpublished data). Second, as the fluorescent marker is different in the self-docking strains (Fig. 2b) , these can be used as integrase 'driver' line, to provide integrase in trans, after a cross to an existing characterized differently marked standard docking strain. In the embryos derived from these crosses, only the attB plasmid needs to be injected, and screening of a G 0 outcross to the wild type will detect those transgenics that only carry the donor plasmid and not the integrase marker.
Here we describe the step-by-step procedure for the efficient site-specific transformation of A. gambiae using established docking strains. An outline is provided in Figure 3 . The protocol includes the preparation of the embryos for injection, the in vitro synthesis of integrase-encoding mRNA and the selection of transgenic mosquitoes up to the establishment of homozygous lines. We have emphasized the procedure for in vitro production of mRNA-encoding integrase and the associated care, as this procedure is likely to be the entry point for ΦC31-mediated transgenesis in other mosquito or insect species lacking refined molecular tools, such as a characterized promoter to drive efficient ΦC31 integrase expression. In addition, we have included a video to document the delicate initial step of embryo alignment. 
MaterIals

REAGENTS
A. gambiae attP-docking strains or self-docking strains (see Table 1 for strains available from the authors) ΦC31 integrase-containing plasmid, e.g., pET11ΦC31poly(A) 35 Fluorescence stereomicroscope or macroscope (e.g., AZ100, Nikon) with appropriate filter sets UV light to visualize gels (e.g., Chemidoc, Bio-Rad) Spectrophotometer (e.g., ND-1000, NanoDrop) Oviposition chambers, custom-built (Equipment Setup) REAGENT SETUP Embryo harvesting Rear mosquitoes according to standard protocols with an adequate larval density:food ratio to obtain large and healthy mosquitoes that will emerge synchronously (MR4 standard protocol http://www.mr4. org/Publications/MethodsinAnophelesResearch.aspx). Approximately 7 d before injection, prepare a large cage (30 × 30 × 30 cm) with freshly emerged adults (about 200 females and 100 males) and provide sugar (10% (wt/vol) sucrose) ad libitum. Four days after emergence, ensure efficient blood feeding of females. Females will be able to lay suitable eggs on the 3rd and 4th days after feeding. For embryo collection, place a small amount of deionized water in the cap of an oviposition chamber (Equipment Setup), place the chamber on the cap and introduce about ten females through the dam (Fig. 4) . Place the chamber in the dark to allow females to lay eggs over a 20-min period. Set up two oviposition chambers to ensure enough eggs for each injection series. Remove the females and leave the eggs in the tube cap for 30 min in the insectary until they begin to melanize to light gray. At that stage, they are suitable for alignment and injection 24, 25 and should be transferred to the injection room conditioned at 18-20 °C to slow down embryo development. Such embryos should be injected within 2 h of laying to ensure optimal development of the embryos. After this time, chorion hardening may render the eggs difficult to inject. Under optimal rearing conditions, at least 250 eggs can be recovered from each chamber.  crItIcal Females need to be inseminated for egg laying. If females do not lay eggs, check that females are inseminated by dissecting the spermathecae of 5-10 females. FC31 integrase-containing plasmid For in vitro transcription of mRNAs encoding ΦC31 integrase, a plasmid containing the gene encoding ΦC31 integrase coupled with an RNA polymerase promoter is required. We use the original pET11ΦC31poly(A) 35, 36 provided by M. Calos. Other transcription plasmids containing mutated and insect codon-optimized ΦC31 integrase have been designed with the aim to increase transformation efficiency, but such improvements have not been observed in A. aegypti or A. stephensi 14, 31 .
•
Transgene-containing plasmid The transgene has to be cloned into a recipient plasmid that contains an attB attachment site plus a screening marker that is distinguishable from the one present in the docking strain. Several plasmids with an attB site associated with different fluorescent proteins under control of the 3xP3 promoter have been already constructed for ΦC31 transformation of Aedes and Anopheles mosquitoes and are available from the respective laboratories 37, 40, 41 . Information on the ΦC31 phage sequence can be found at the European Nucleotide Archive accession number AJ006589, and information on the 3xP3s synthetic promoter can be found at the DNA Data Bank of Japan accession number AB779767.1 and at http://flybase. org/reports/FBtp0017474.html. Microinjection buffer, 1×, pH 7.2 Add 0.1 ml of 0.1 M sodium phosphate buffer (pH 7.2) and 1 ml of 0.5 M KCl to deionized water. Adjust the volume to 100 ml. Filter-sterilize the buffer (0.22 µm), divide it into small volumes and store it at 4 or −20 °C. Water-saturated halocarbon oil Mix 9 ml of halocarbon oil 700, 1 ml of halocarbon oil 27 and 10 ml of molecular biology-grade water gently to avoid forming an emulsion. Leave it to stand at room temperature (20-22 °C) overnight to allow the halocarbon oil to become water saturated. EQUIPMENT SETUP Oviposition chambers Cut the bottom of a 50-ml polypropylene tube and cover this opening with a piece of dental dam latex. Make a small cut in the membrane to introduce mosquitoes. A piece of lab latex glove can be used as an alternative to a dental dam. Add deionized water to the cap of the polypropylene tube to serve as the oviposition site (Fig. 4) . Pulling needles for microinjection We have used both quartz and aluminosilicate glass needles. Pull the quartz needles using the following parameters on a Sutter P-2000: HEAT 750, FIL 4, VEL 40, DEL 150 and PUL 165, which are similar to those described in Lobo et al. 24 . Pull alumino-silicate needles using the following parameters: HEAT 430, FIL 120, VEL 50, DEL 210 and PUL 250. Parameters may need to be adjusted slightly depending on the accuracy of the alignment of individual P-2000 pullers and variation in needle batches. It is useful to pull a large number of needles to replace those that break or get clogged during injections (usually about five needles per 150 embryos). Pulled needles are stored on modeling clay in a closed Petri dish at room temperature until use. The tip of the needles is sealed during pulling, but it will usually open sufficiently when you attempt to inject the first embryo.  crItIcal Although quartz micropipettes are more expensive than alumino-silicate glass needles, and they require the higher temperature of a laser puller, they perform better. Some researchers have also been successful in using commercial Femtotips 27 . Quartz needles are more resistant than other glass needles to the damage that is often caused during the penetration of the hard embryo chorion. The presence of filaments increases flow, which aids the filling of the injection needle and solution flow while injecting.  crItIcal Wear gloves when pulling the needles to avoid degradation of mRNA while injecting embryos if mRNA is used as a source of integrase.  crItIcal If the needle shape after pulling is not reproducible, first check the quality of the needle batch. If the puller is not reproducible, refer to the puller's setup instructions. It is crucial to use and maintain the needle puller correctly to obtain pulled needles of reproducible quality. Filling needles Back-fill the needles with 3-5 µl of plasmid or plasmid/mRNA mix using Microloader pipette tips (Eppendorf). Injection slides and embryo alignment coverslips Tape two coverslips on a glass slide 1 cm apart. Place a piece of double-sided sticky tape on the edge of each coverslip, which will later receive the coverslip with aligned embryos. Prepare coverslips for collecting aligned embryos by placing one piece of double-sided sticky tape on each. Prepare an excess of small squares of filter paper with sharp scissors to minimize fibers (see Supplementary Video 1) . Injection slides and coverslips can be prepared in advance, and they can be stored indefinitely in a dust-free environment. Screening methods and fluorescence microscopy Screening of fluorescent larvae can be done with most fluorescence microscopes with appropriate filter sets to distinguish between the different fluorescent markers 39, 45 .
For ECFP, use a 421/456-nm activation and 461/504-nm emission filter set and for dsRed, use a 538/588-nm activation and 600/652-nm emission filter set. We favor the use of a stereomicroscope or AZ100 Nikon macroscope, owing to the convenience of handling specimens. There are multiple methods available to screen G 1 larvae en masse, which all rely on reducing the mobility of the larvae, either by chilling or filtering, while keeping them moist, so that they can be viewed under a stereoscope and fluorescent transformants can be easily recovered. One simple method that can be used involves filtering on cellulose discs and preservation on damp sponges during manipulation. For this method, prepare 90-cm disks of 100% cellulose filter papers to fit into Petri dishes. Draw lines 0.5 cm apart to screen larvae by row (Fig. 5) . This will facilitate orientation under the microscope and it will enable the complete screening of large batches of larvae.
proceDure preparation of plasmid Dna carrying the transgene • tIMInG 3 d  crItIcal To avoid RNA degradation, Steps 1-31 and 38-39 (i.e., up to embryo injection) have to be carried out in an RNase-free environment when injecting standard docking strains with mRNA encoding the ΦC31 integrase. Clean the bench and pipettes with an RNase Away spray. Always wear gloves during preparation of mRNA, from establishing the culture to the final mix preparation. Use RNase-free microfuge tubes.  crItIcal It is best to make fresh (<10 d) preparations of DNA and mRNA. We used to make the injection mix the week before injections. For long-term storage, store the nucleic acid preparations in RNase-free 70% (vol/vol) ethanol.  crItIcal We recommend verifying the quality and identity of the plasmid to be injected at the relevant steps, as the whole process to obtain transgenic mosquitoes takes 2-3 months.
1|
Once the DNA of interest is cloned in an attB-recipient vector and its sequence is verified, make a fresh transformation of the plasmid according to standard protocols.  crItIcal step To obtain a good yield, it is necessary to make a culture from a freshly transformed clone.  crItIcal step We recommend using SURE2 cells (Stratagene) to avoid recombination during bacterial growth.  crItIcal step If you are using mRNA as a source of integrase, Step 9 can be carried out in parallel to Steps 1-4.
2|
The next day, grow a single colony in 1 ml of LB supplemented with 100 µg/ml ampicillin for 8 h at 220 r.p.m. at 37 °C with aeration.
3|
Transfer 100 µl to a 1-liter flask containing 100 ml of LB broth and 100 µg/ml ampicillin, and allow it to grow overnight at 240 r.p.m. at 37 °C with aeration.
4|
Extract the plasmid DNA with an endotoxin-free purification kit according to the manufacturer's instructions. Elute DNA with 500 µl of prewarmed nuclease-free water. Measure the DNA concentration with a NanoDrop spectrophotometer (250-500 µg should be recovered). Confirm the identity of the plasmid by restriction enzyme digestion.
5|
Precipitate plasmid DNA with 0.1 volumes of 3 M sodium acetate and 2.5 volumes of 100% ethanol, for 30 min at −20 °C.  crItIcal step It is possible to divide DNA into smaller quantities before ethanol precipitation to avoid potential DNA degradation upon repetitive freezing and thawing.
6|
Centrifuge the DNA at 15,000g for 15 min at 4 °C.
7|
Wash the DNA with 1 ml of 70% (vol/vol) ethanol (100% ethanol diluted in nuclease-free water).  pause poInt Plasmid DNA can be stored for at least 6 months in 70% (vol/vol) ethanol at −20 °C until use.
(optional) preparation of Dna injection mix • tIMInG variable; 1-2 h 8| (Optional) If you are using self-docking strains, follow option A, and if you are using helper integrase plasmid follow option B. Otherwise, proceed directly to Step 9 to prepare integrase mRNA.
(a) self-docking strains (i) Centrifuge attB plasmid DNA from Step 7 at 15,000g for 5 min at 4 °C.
(ii) Air-dry the DNA pellet for 5 min and resuspend it at ~300 ng/µl in 1× injection buffer. (iii) Measure the DNA concentration with a NanoDrop spectrophotometer to ensure that no DNA has been lost during the precipitation. Also check the DNA purity by measuring the optical density (OD) at 260 nm/280 nm (OD 260/280 ), which should not be <1.8. (iv) Spin the DNA suspension again at 15,000g for 5 min to remove any particulates. The DNA is now ready for injection at
Step 38. Step 38.
mrna Φc31 integrase synthesis • tIMInG 4-6 d 9| Transform pET11-ΦC31polyA integrase-containing plasmid, establish cultures, extract the plasmid DNA and confirm the plasmid identity as described in Steps 1-4.  pause poInt The DNA can be stored safely for at least 3 months at −20 °C until required.
10| Linearize 40 µg of pET11-ΦC31polyA plasmid with BamHI HF at 37 °C overnight, as recommended by the manufacturer but by using RNASE-free water as a diluent.
11|
Next morning, check for the completion of digestion by running an aliquot (500 ng) on a 1% (wt/vol) agarose gel in 1× TAE buffer; a unique band at 8 kb is expected.
12|
Stop the digestion and precipitate the digested plasmid by adding a one-twentieth volume of 0.5 M EDTA, a one-tenth volume of 3 M sodium acetate and two volumes of 100% ethanol. Leave the mixture for 30 min at −20 °C.
13|
Centrifuge it at 15,000g for 15 min at 4 °C.
14|
Rinse the pellet with 1 ml of 70% (vol/vol) ethanol (100% diluted in RNase-free water).
15|
Centrifuge the tube at 15,000g for 5 min at 4 °C.
16|
Remove the supernatant and air-dry the DNA pellet before adding 40 µl of RNase-free water. Verify that the DNA concentration is around 1 µg/µl with a NanoDrop spectrophotometer, and then run an aliquot of the purified linear template on an agarose gel for quality control.  pause poInt The linear DNA can be stored safely for at least 1 month at −20 °C until required.
17|
Perform in vitro ΦC31 integrase mRNA synthesis using the T7 ULTRA mMessage mMachine kit according to the manufacturer's instructions. To inject ~2,000 embryos, about 250 µg of mRNA is required. This amount can be obtained from four reaction tubes, each using 1 µg of the digested T7 ΦC31 integrase DNA template from Step 16. Incubate at 37 °C for at least 4 h (can safely be left overnight).
18| (Optional) Remove the DNA template using TURBO DNase (included in the in vitro mRNA synthesis kit) and add a poly(A) tail to the mRNA by following the manufacturer's instructions. Although inclusion of this step adds to the overall time, it results in higher purity and stability of the mRNA, and it might increase the number of site-specific integration events.  crItIcal step Remove 2.5 µl per RNA sample before adding the poly(A) polymerase and keep it on ice; this control will be run on a gel next to the tailed mRNA after mRNA purification at Step 20.  crItIcal step Always keep the mRNA on ice and proceed directly to purification (Step 19).
19| Purify the mRNA using the MEGAclear kit according to the manufacturer's instructions. Use one column per two mRNA reactions. Elute each column with 2 × 50 µl of supplied elution solution prewarmed at 95 °C. Pool the 200 µl of eluted mRNA and keep it on ice.
20|
Measure the mRNA concentration with a NanoDrop (200-260 µg should be recovered). Verify the mRNA quality on an agarose gel run at 50 V; before loading, denature 2.5 µl of mRNA (untailed mRNA sample and tailed mRNA sample from
Step 18) and 3 µl of ssRNA ladder in ssRNA buffer according to the manufacturer's instructions. The untailed ΦC31 integrase mRNA should be 1,840 bp, whereas the tailed mRNA, if
Step 18 was performed, should be over 2,000 bp.
21|
Precipitate the mRNA with the 5 M ammonium acetate supplied in the MEGAclear kit according to the manufacturer's instructions.  pause poInt mRNA can be stored when in 70% (vol/vol) ethanol (100% ethanol diluted in nuclease-free water) at −20 °C for 3 d. After this step, there is no other pause point until storage of the injection mix at Step 31.
22|
Recover the precipitated mRNA by centrifugation at 15,000g for 15 min at 4 °C, and rinse it with RNase-free 70% (vol/vol) ethanol. Resuspend the air-dried pellet in 200 µl of nuclease-free water prewarmed at 65 °C and keep the tube on ice.  crItIcal step Do not air-dry the pellet too much, as it will be difficult to resuspend.
23|
Use a NanoDrop to determine the mRNA concentration to verify full recovery of mRNA after precipitation. Check the mRNA purity by measuring the OD 260/280 , which should be ~2.0. Proceed directly to injection mix preparation.
preparation of Dna-mrna mix for injection • tIMInG 1-2 d 24|
Centrifuge the plasmid DNA from Step 7 at 15,000g for 5 min at 4 °C.
25|
Air-dry the DNA pellet for 5 min and resuspend it at about 1 µg/µl in nuclease-free water.
26|
Measure the DNA concentration to ensure that no DNA has been lost during the precipitation. Also use a NanoDrop to check the DNA purity by measuring the OD 260/280 , which should not be <1.8.
27|
According to the concentration of the purified plasmid DNA (from Step 26), add an adequate volume of plasmid DNA to the purified mRNA (from Step 23) to recover the recommended concentration after co-precipitation in 1× injection buffer. Plasmid DNA is injected at a concentration of 250 ng/µl (if plasmids are under 12 kb), and mRNA-encoding ΦC31 integrase is injected at a concentration of 800-1,000 ng/µl.  crItIcal step When larger plasmids are used, we have observed a decrease in transformation efficiency. To increase the efficiency, increase the DNA concentration up to 350 ng/µl. However, high concentrations can clog the needles. This can be limited by using a needle with a larger tip; however, a larger tip will result in a decrease in embryo survival 24 .
28| Precipitate the DNA-mRNA mix with 5 M ammonium acetate (supplied in the MEGAclear kit) according to the manufacturer's instructions. After the 70% (vol/vol) ethanol wash and centrifugation, resuspend the air-dried pellet in 1× injection buffer prewarmed at 65 °C; keep the tube on ice.  crItIcal step Do not air-dry the pellet too much, as it would be difficult to resuspend.
29|
Filter the mix with a 0.22-µm microfilter at 13,000g for 5 min at 4 °C.
30|
Verify the injection mix quality on a 1% (wt/vol) agarose gel run at 50 V, running side by side 3 µl of denatured filtered injection mix, 500 ng of plasmid DNA preparation from Step 26 and 3 µl of ssRNA ladder in ssRNA ladder buffer. The plasmid DNA should present two bands, corresponding to different types of circular DNA structure, and the mRNA should be over 2 kb.
31| Prepare 15-µl samples of the injection mix and store them on ice. Small aliquots are recommended, as mRNA production is expensive and mRNA is sensitive to degradation.  pause poInt Store the aliquots at −80 °C for up to 2 weeks until embryo injections. The mix should not be refrozen once it is thawed.
embryo alignment • tIMInG 10-20 min per batch of 50 embryos  crItIcal Methods for aligning Anopheles eggs have been well described [24] [25] [26] [27] 46 . Our procedure is very similar to those described in 24, 26 . As the method is intricate, we provide a video (supplementary Video 1).  crItIcal For alignment and injections, condition the room at 18-20 °C to slow down embryo development.
32|
Place a small square of filter paper on a glass slide and add a drop of 25 mM NaCl to moisten the paper, leaving a fine line of buffer around the edges. Ensure that no air bubbles are trapped between the paper and the glass slide.
33| Deposit a drop of 25 mM NaCl on the glass slide near the edge of the filter paper.
34|
With a fine paintbrush, transfer about 50 embryos into the drop of NaCl. Align the embryos against the filter paper, which should be wet enough to ensure that the embryos are in contact with the solution but not so wet that it attracts them. Align 30-50 eggs with the anterior pole (the larger one) against the paper and with the dorsal side (flattened one) facing up.  crItIcal step Do not let the embryos become dry. If needed, add drops of 25 mM NaCl to the paper to maintain moisture as required.
35|
Once the embryos are aligned, absorb the solution from the wet filter gently but quickly with fresh filter paper. This will allow the embryos to partially desiccate.
36|
Remove the alignment filter paper gently, and then apply the coverslip to glue the embryos to the tape. Turn over the coverslip and immediately cover the embryos with a drop of 25 mM NaCl or halocarbon oil.  crItIcal step Both 25 mM NaCl and halocarbon oil have been used successfully for A. gambiae transformation 33, 47 . The use of halocarbon oil has the advantage of improved visibility of both the embryos and needle tip, and it improves the delimitation of the periplasm space and yolk in the embryos. However, its use requires an additional step of oil removal to ensure a high survival rate of the injected embryos.
37|
Position the coverslip on the injection slide (see Equipment Setup) and transfer it to the microscope stage for injection.
To inject a large number of eggs, it is convenient to work in teams of two persons, one aligning and one injecting. This way, it is possible to inject continuously.  crItIcal step The quality of eggs is of great importance for transformation success. We select embryos on the basis of several criteria, as described by Lobo et al. 24 , to maximize survival after injection. White or yellowish eggs, eggs that are too dark, small or thin eggs, and those with visible defects in the chorion or in their morphology are discarded. Moreover, we try to align eggs that are at a similar melanization stage, which facilitates injecting, as they have similar chorion hardness. The level of desiccation is also crucial. Underdesiccated embryos will expel yolk after the injection needle is removed and are likely to die; overdesiccated embryos will be soft and difficult to inject, and they are more likely to sustain serious damage. A set of aligned uninjected embryos can be used as a quality control for hatching rate, which should be 95-100%, leading to an adult emergence rate of about 80% in optimal conditions. embryo microinjection • tIMInG 4-8 d  crItIcal Injections are carried out at 200× magnification, as previously described 24, 25 .
38| Thaw an aliquot of the injection mix on ice. If you are injecting a self-docking strain, use the injection mix from
Step 8A. If you are using a helper plasmid as the source of integrase, use the injection mix from Step 8B. If mRNA is being used as an integrase source, use the injection mix from Step 31.
39|
Fill a pulled needle (see Equipment Setup) with 3-5 µl of injection mix, and then mount it on the micromanipulator.
40|
Focus on the embryo floats and gently position the needle until it is visible in the same optical field. The angle of the needle from the horizontal coverslip plane should be between 15 and 30 degrees.
41|
Set up the parameters of the Femtojet Express (constant pressure Pc and injection pressure Pi). They should be adjusted depending on the capillary size, the embryo batch and the state of maturation and desiccation. Generally, Pc is ~1,000 HPa and Pi varies between 2,000 and 3,000 HPa. If you are injecting under halocarbon oil, the droplet size can be monitored between injections by injecting into the oil and adjusting the FemtoJet parameters to give the required droplet size. If the needle is very thin and properly broken, injections can be administered by using the CLEAN function, and no resistance should be felt during chorion penetration.
42|
Inject embryos on the ventral side, which faces up, at the posterior pole (the thinner one), between the posterior of the floats and the posterior pole of the embryo. Inject as much mix as the embryo can support without inflicting damage. Inject as many eggs as required.  crItIcal step Do not inject in the terminal end of the posterior pole, as it is harder and thus more difficult to penetrate with a needle. A useful drawing can be found in Lobo et al. 24 . Depending on the manipulator preference, injection can be performed either by moving the microscope plate or by moving the needle with the joystick of the micromanipulator. The tip of the needle should open on first contact with an embryo.  crItIcal step To prevent clogging and to check that the needle is not clogged, use the CLEAN function between each injected embryo. Change the needles that cause excessive embryo damage. An embryo that continues to lose yolk material from the wound site will not survive.
? troublesHootInG 43| Submerge the coverslip supporting injected embryos in a dish with about 1 cm of deionized sterilized water supplemented with artificial sea salts. If you are injecting under halocarbon oil, position the coverslip vertically to allow the oil to flow away from the eggs.  crItIcal step Do not add food until the larvae hatch to avoid microbial development that might impair embryo recovery from injection.
44|
Discard the remaining thawed injection mix at the end of the injection day. Transfer the vessels containing the injected eggs to insectary conditions until larvae hatching (48-72 h after injection).  crItIcal step By following this protocol, a hatching rate of 25-50% can be obtained using the standard docking strains; a rate of up to 60% can be obtained with the self-docking strains, in which less nucleic acid is injected. (Fig. 6) . In recent experiments, we observed that more transformants are recovered from progeny of G 0 larvae expressing transient fluorescence than from progeny of G 0 larvae that do not (E.P. and N.P., unpublished data). Therefore, breeding only from G 0 larvae expressing transient fluorescence can save time and space for G1 production, rearing and screening. To increase genetic diversity, the wild-type strain, rather than the docking strain, can be used for outcrossing if required.  crItIcal step As A. gambiae mosquitoes need large amounts of space to mate, use cages or boxes with a minimum volume of 2 liters for crosses, as this will ensure a minimum of 75% mated females in 4 d.
51|
Collect G 0 females over 1 week and place them all together in a large cage (30 × 30 × 30 cm); backcross them to a fivefold excess of mature virgin males (older than 3 d) from the docking strain.  crItIcal step As A. gambiae mosquitoes need large amounts of space to mate, use cages or boxes with a minimum volume of 2 liters for crosses, as this will ensure a minimum of 75% mated females in 4 d.
52|
Blood-feed the females from each cross (G 0 males × docking females; G 0 females × docking males) 4-5 d after establishing crosses.
53|
Collect the first batch of eggs and provide a second and even a third blood-meal, and collect eggs after each blood-meal to obtain additional progeny. In our experience, we have not observed transgenics in the third batch if none were present in the first two batches. However, under normal conditions, in which transformants are observed in the first two batches, a third batch allows more G 1 -positive larvae to be collected, helping with transgenic line establishment.
54|
Control the G 1 larval density and food quantities carefully to maximize larval survival, as described in Step 46.
screening G 1 transgenic larvae • tIMInG 4-6 d 55| Collect 200 to 300 larvae, preferably L3-L4 stages, and place them on an 8-cm-diameter circular cellulose paper on top of a moist sponge (Fig. 5) . Let the sponge absorb enough water so that larvae do not move, while keeping enough moisture to preserve the larvae.  crItIcal step Remove food from the water before pipetting larvae; otherwise, it will result in autofluorescence background during the screen.
56|
To select transgenic larvae, transfer the filter paper containing the larvae to a Petri dish under the fluorescence stereomicroscope and locate larvae expressing fluorescence in both the eyes and the anal papillae.  crItIcal step We frequently observe G 1 larvae with fluorescence restricted to one eye or both eyes and that showed no expression in the anal papillae, as expected from expression driven by the 3xP3 promoter (Fig. 7) . They are presumably falsepositive transgenic G 1 , as no stable transgenic progeny have been obtained from these larvae (E.P. and N.P., unpublished data). Nevertheless, we noticed that the presence of such larvae is correlated with finding genuine transgenic larvae in the same G 1 batch. In addition, we observed this type of larvae only in G 0 female progeny (E.P. and N.P., unpublished data), a b suggesting that the false-positive signal might be generated from the injected DNA plasmid maintained as an episome from the injected embryo over one generation.
? troublesHootInG 57| Carefully transfer transgenic G 1 larvae with a fine paintbrush back to small trays filled with their previous rearing water. Add a small amount of food and rear the larvae normally until adult emergence.
establishment of homozygous transgenic lines
• tIMInG 2 months 58| At G 1 adult emergence, separate the males and females into two different cages and backcross them when they are sexually mature by using a 20-fold excess of the opposite sex from the docking strain.
59| Blood-feed the cages two or three times to maximize the numbers of transgenic mosquitoes obtained. In the G 2 generation, select only fluorescent larvae, which should represent 50% of total larvae.
60| From a subset of fluorescent larvae, extract genomic DNA using standard methods 47 and confirm by PCR the presence of the canonical ΦC31 recombination sequences attL and attR (see supplementary table 1 for primers and PCR parameters) and the presence of transgene (using transgene-specific primers). At this stage, fluorescent larvae are heterozygous and should be positive for attP, attL and attR. It is advisable to verify the integrity of the transgene by PCR cloning and sequencing.
61|
Intercross G 2 -positive heterozygous mosquitoes and blood-feed them.
62| Select G 3 homozygous larvae on the basis of higher fluorescence intensity than that of heterozygous larvae. At this stage, about 25% of larvae should be homozygous for the integrated transgene if it has no harmful effect.  crItIcal step Keep an amplified backup of the heterozygous transgenic mosquitoes until establishment of the homozygous line. Moreover, try to keep at least two independent pools derived from the transgenic G 1 mosquitoes (progeny from G 0 males and G 0 females, for example). ΦC31 integrase is a site-specific transformation system, and in our experience with A. gambiae we have not yet observed nonspecific integration. However, insertions into pseudo-attP sites cannot be excluded, as they are documented in mammalian and Drosophila cells, as well as in the mosquito A. aegypti 36, 40, 48 .
Maintaining two independent heterozygous lines should ensure that one of the lines contains the insert at the expected site.
63|
Extract DNA from the leg of each G 3 mosquito to be used for intercrossing using the RedExtract-N-Amp tissue genomic DNA extraction kit according to the manufacturer's instructions, except that volumes are fivefold reduced. Perform PCR on the extracted DNA as described in
Step 60; homozygous mosquitoes should be attL-and attR-positive but attP-negative.
64|
Set up inter-crosses with G 3 homozygous adult mosquitoes and blood-feed them to obtain a homozygous line in G 4 .
65|
Check that the line is homozygous in subsequent generations by fluorescence and by PCR. . (a-d) G 0 embryos of an ECFP docking strain were injected with an attB plasmid containing EYFP under the control of the 3xP3 promoter. Some G 1 larvae from G 0 females express the EYFP screening marker in one eye (a) or two eyes (c), whereas the ECFP marker of the docking strain, also under the control of the 3xP3 promoter, is well expressed from the eyes to the anal papillae (b,d). Scale bars, 1 mm.
• tIMInG Steps 1-7, preparation of plasmid DNA carrying the transgene: 3 d
Step 8, (optional) preparation of DNA injection mix if using self-docking strains or helper plasmid: 1-2 h antIcIpateD results By using this protocol with the standard docking strain E (see table 1), injection of roughly 2,000 embryos should be sufficient to produce a transgenic line (assuming no toxicity of the expressed transgene), with a mean embryo survival rate of ~25%. This can be achieved in 2-4 d of injections, depending on the experience of the injector and the help of a second person to align the eggs. With the self-docking strains, injection of 1,000-1,500 embryos is usually sufficient for obtaining The rearing conditions are not optimal Control your rearing conditions to maximize mosquito survival and fecundity
The transgene may be toxic Attempt to inject a neutral transgene
